Meanwhile, 25 more patients died from Covid-19, taking the fatalities to 5,886.
So far, 321,281 patients (79.38 percent) have recovered -- 1,548 in the last 24 hours.
The fatality rate in Bangladesh is 1.45 percent, the Directorate General of Health Services said.
Bangladesh reported its first cases on March 8. The number of cases reached the 300,000-mark on August 26. The first death was reported on March 18 and the death toll exceeded 5,000 on Sept 22.
So far, 2,310,589 tests have been carried out, including 14,268 new tests, and 17.52 percent of them have turned out positive.
Bangladesh is seeing 2376.66 infections, 1886.49 recoveries and 34.56 deaths per million.
Currently, there are 77,593 active coronavirus cases in the country.
Of the total victims, 4,529 are men and 1,357 are women. Of the latest 25 victims, 20 are aged above 50 years, three between 41 and 50 years and two others are aged between 21 and 30 years.
So far, 3,053 people have died in Dhaka division, 1,169 in Chattogram, 370 in Rajshahi, 466 in Khulna, 199 in Barishal, 242 in Sylhet, 262 in Rangpur and 122 in Mymensingh.
Across the country, 12,051 people are now in isolation and 39,615 in quarantine.
Global situation
The global confirmed cases surpassed 44 million on Thursday, according to the latest tally from Johns Hopkins University (JHU).
The data show that Covid-19 cases reached 44,400,318 with 1,173,270 fatalities.
Also read: Global Covid-19 cases top 44 mln
The US has registered over 227,663 deaths and more than 8.8 million infections – the highest in the world.
Brazil, which has the world's second-highest Covid-19 death toll and the third-largest number of cases, has registered 5,468,270 cases with 158,456 deaths as of Thursday.
India has recorded a total of 7,990,322 cases while its death toll reached 120,010, JHU data showed.
Meanwhile, a massive second wave of Covid-19 infections has prompted European countries to tighten their preventive measures, including reimposing lockdowns, to stem the spread of the coronavirus.
Also read: Russia permanently registers Favipiravir for COVID-19 treatment